Severe Respiratory Diseases
Severe respiratory diseases
Around 100,000 people worldwide suffer from Cystic Fibrosis, the most common severe genetic disease. This multi-organ disease mainly affects the lungs, which are hit by chronic infections and inflammations that cause their progressive deterioration.
*Sources: ECFS Patient Registry, Report 2015
200
New cases of Cystic Fibrosis every year in Italy
Source: ECFS Patient Registry, Report 2015
48%
Cases of Cystic Fibrosis affecting children in Europe
Source: ECFS Patient Registry, Report 2015
We want to develop treatments that play a key role in treating Cystic Fibrosis, as well as in managing severe respiratory diseases
PIPELINE - Respiratory Tract
Preclinical
Phase 1
Phase 2
Phase 3
Phase 4
Anti Mycobacterial
New Antifungal
New Peptide
Antioxidant
CF
NCFBE-1
NCFBE-2
BOS
OUR DIRECT PRESENCE
PARTNERNING OPPORTUNITIES
Business Development Department
+39 02 66524455
FIND OUT MORE ABOUT OTHER TOPICS
Our focus
Zambon's daily commitment: improving the lives of patients.